Streptococcus milleri-sepsis with lung and brain abscesses

Acta Clinica Belgica

Volumn 59, Issue 6, 2004, Pages 369-372

  Velghe, Anja ^a   Van Den Noortgate, N ^a   Janssens, W ^a   Smeets, P ^a   Vogelaers, D ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Abscesses; Bacteremia; Streptococcus milleri

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CLINDAMYCIN; PENICILLIN G;

ABSCESS DRAINAGE; AGED; ARTICLE; BACTEREMIA; BACTERIAL FLORA; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BRAIN ABSCESS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG MEGADOSE; ENDOPHTHALMITIS; HUMAN; LUNG ABSCESS; MALE; SEPSIS; STREPTOCOCCUS MILLERI; THORAX RADIOGRAPHY;

EID: 15444380818     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2004.054     Document Type: Article

References (13)

1. Belko J, Goldmann DA, Macone A, Zaidi AKM. Clinically significant infections with organisms of the Streptococcus milleri group. Pediatr Infect Dis J 2002;21:715-26.
2. Casariego E, Rodriguez A, Corredoira JC et al. Prospective study of Streptococcus milleri bacteremia. Eur J Clin Microbiol Infect Dis 1996;15:194-200.
3. Jacobs JA, Pietersen HG, Stobberingh EE, Soeters PB. Bacteremia involving the "Streptococcus milleri" group: analysis of 19 cases. Clin Infect Dis 1994;19:704-13.
4. Whiley RA, Beighton D. Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius and Streptococcus anginosus as distinct species. Int J Syst Bacteriol 1991;41:1-5.
5. Clarridge JE III, Osting C, Jalali M, Osborne J, Waddington M. Genotypic and phenotypic characterization of "Streptococcus milleri" group isolates from a veterans administration hospital population. J Clin Microbiol 1999;37:3681-7.
6. Bert F, Bariou-Lancelin M, Lambert-Zechovsky N. Clinical significance of bacteremia involving the "Streptococcus milleri" group: 51 cases and review. Clin Infect Dis 1998;27:385-7.
7. Sninzato T, Saito A. The Streptococcus milleri group as a cause of pulmonary infections. Clin Infect Dis 1995;21(suppl 3): S238-43.
8. Wanahita A, Goldsmith EA, Musher DM et al. Interaction between human polymorphonuclear leukocytes and Streptococcus milleri group bacteria. J Infect Dis 2002;185:85-90.
9. Jacobs JA, Stobberingh EE. In-vitro antimicrobial susceptibility of the "Streptococcus milleri" group (Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius). J Antimicrob Chemother 1996;37(2):371-5.
10. Limia A, Jimenez ML, Alarcon T, Lopez-Brea M. Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group. Eur J Clin Microbiol Infect Dis 1999;18(6):440-4.
11. Bantar C, Fernandez Canigia L, Relloso S, Lanza A, Bianchini H, Smayevsky J. Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens. J Clin Microbiol 1996;34:2020-2022.
12. Yamamoto N, Kubota T, Tohyama M et al. Trends in antimicrobial susceptibility of the Streptococcus milleri group. J Infect Chemother 2002;8(2):134-7.
13. Tracy M, Wanahita A, Shuhatovich Y, Goldsmith EA, Clarridge JE III, Musher DM. Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains. Antimicrob Agents Chemother 2001;45(5):1511-4.